Asking Price Contact for pricing
Area Size
NOI Net Operating Income N/A
NIY N/A

Documents

I accept the confidentiality agreement
Create an account on the Investor Center to save your search and investment preferences, save and share opportunities, access exclusive documents, and more. More questions? Visit our FAQ. Approval for Deal Room access requires review by our Broker Team. You will be notified by email once your access is granted. More questions? Visit our FAQ. You'll need to sign a Confidentiality Agreement (CA) to access exclusive documents in the Deal Room. Signing the CA means you agree not to divulge or release sensitive information related to this property. More questions? Visit our FAQ.
I accept the confidentiality agreement I accept the confidentiality agreement
Create an account on the Investor Center to save your search and investment preferences, save and share opportunities, access exclusive documents, and more. More questions? Visit our FAQ. You'll need to sign a Confidentiality Agreement (CA) to access exclusive documents in the Deal Room. Signing the CA means you agree not to divulge or release sensitive information related to this property. More questions? Visit our FAQ.

Attributes

Year Built 1968
Building Area Net

Asset Description

Jones Lang LaSalle Americas, Inc. (“JLL”), as exclusive representative for the Owner, is pleased to present this offering for the sale of 12725 Twinbrook Parkway (the “Property”), a vacant 58,880 RSF life science asset strategically located in Rockville, Maryland. The Property offers attractive existing lab infrastructure and the opportunity to reposition into Class A life science tenancy in the heart of Twinbrook, a thriving private and public sector lab cluster.

12725 Twinbrook Parkway is located in the I-270 Corridor life science market, which has a record-low direct vacancy rate of 2.1% and has maintained a sub-5.0% vacancy rate since the beginning of 2016. Furthermore, the Property is situated within the Twinbrook life science cluster, adjacent to the headquarters of the National Institute of Allergy and Infectious Diseases (NIAID), the headquarters of U.S. Pharmacopeia, a 1 million SF U.S. Department of Health and Human Services (HHS) installation, and facilities for the National Institutes of Health (NIH) and other private and federal demand drivers. In total, the Twinbrook cluster features over 2.5 million SF of life science related uses, making it a hotbed of life science activity and innovation.

With convenient access to the greater DC Metropolitan region provided by the Twinbrook Metrorail Station (Red Line), which is a short 7-minute walk away, this investment offering represents an ideal opportunity to enter a premier life science market in a location with walkable amenities that few other properties in the region can offer.

Investment Highlights

  • Vacant Life Science Repositioning Opportunity Totaling 58,880 RSF
  • Substantial Existing Infrastructure and Attractive Building Bones to Deliver High-Quality Lab Space
  • Maryland’s I-270 Corridor Offers Robust Life Science Fundamentals with a 2.1% Direct Vacancy Rate and 11.9% Rent Growth over the last 12 Months
  • Located in Twinbrook, a Vibrant Cluster Featuring 2.5 Million SF of Life Science Related Uses
  • Steps from the Headquarters of National Institute of Allergy and Infectious Diseases (NIAID) and U.S. Pharmacopeia
  • Walkable to Metro (Red Line) in 7 Minutes and Less than a 15-Minute Walk to Premier Amenities including a Future 80,000 SF Wegmans
Last Updated Date: 14 Nov 2022

There was an error submitting your request. Please try again, or submit you inquiry here.

 

PRIVACY NOTICE

Jones Lang LaSalle (JLL), together with its subsidiaries and affiliates, is a leading global provider of real estate and investment management services. We take our responsibility to protect the personal information provided to us seriously.

Generally the personal information we collect from you are for the purposes of dealing with your enquiry.

We endeavor to keep your personal information secure with appropriate level of security and keep for as long as we need it for legitimate business or legal reasons. We will then delete it safely and securely. For more information about how JLL processes your personal data, please view our privacy statement.

Last Updated Date: 14 Nov 2022

Do you have any questions?  Visit our FAQ page

JLL  financing

JLL can help you finance and manage your portfolio.
Email us today to see how we can help achieve your ambitions.